Enhanced Delivery of Rapamycin by V156K-apoA-I High-Density Lipoprotein Inhibits Cellular Proatherogenic Effects and Senescence and Promotes Tissue Regeneration

High-Density Lipoprotein (HDL) From Elderly and Reconstituted HDL Containing Glycated Apolipoproteins A-I Share Proatherosclerotic and Prosenescent Properties With Increased Cholesterol Influx

(2011) K.-H. Park et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion

(2010) Michelle A. Fryirs et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Anti-inflammatory effects of apolipoprotein A-I in the rabbit

(2010) Sanjay Patel et al.   ATHEROSCLEROSIS

Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence

(2010) Ki-Hoon Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents

(2010) Takeshi Kimura et al.   CIRCULATION

The mTOR Pathway: A New Target in Cancer Therapy

(2010) L. Ciuffreda et al.   CURRENT CANCER DRUG TARGETS

Association of a Functional Polymorphism in the Cholesteryl Ester Transfer Protein (CETP) Gene With Memory Decline and Incidence of Dementia

(2010) Amy E. Sanders   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus

(2010) Ansgar S. Olsen et al.   WOUND REPAIR AND REGENERATION

Lipid transfer proteins: Past, present and perspectives

(2009) Eder C.R. Quintão et al.   ATHEROSCLEROSIS

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

(2009) M. J. Chapman et al.   EUROPEAN HEART JOURNAL

A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation

(2009) Kyung-Hyun Cho et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients

(2009) Kyung-Hyun Cho et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Enhanced Delivery of Adenovirus, Using Proteoliposomes Containing Wildtype or V156K Apolipoprotein A-I and Dimyristoylphosphatidylcholine

(2009) Ki-Hoon Park et al.   HUMAN GENE THERAPY

Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL

(2009) Kyung-Hyun Cho   MOLECULES AND CELLS

High-density lipoproteins, inflammation and oxidative stress

(2008) Fatiha Tabet et al.   CLINICAL SCIENCE

High-density lipoprotein/apolipoprotein A-I infusion therapy

(2008) Jean-Claude Tardif et al.   Current Atherosclerosis Reports

Fgfs control homeostatic regeneration in adult zebrafish fins

(2008) A. A. Wills et al.   DEVELOPMENT

Reviewing the Evidence for De Novo Immunosuppression With Sirolimus

(2008) S.M. Flechner   TRANSPLANTATION PROCEEDINGS